Leukocyte-derived ratios are associated with late-life any type dementia: a cross-sectional analysis of the Mugello study
Authors:
- Gemma LombardiGLGemma Lombardi
- Roberto PaganelliRPRoberto Paganelli
- Michele AbateMAMichele Abate
- Alex IrelandAIAlex Ireland
- Raffaele Molino-LovaRMRaffaele Molino-Lova
- Sandro SorbiSSSandro Sorbi
- Claudio MacchiCMClaudio Macchi
- Raffaello PellegrinoRaffaello Pellegrino
- Angelo Di IorioAIAngelo Di Iorio
- Francesca CecchiFrancesca Cecchi
Open Access
- 21 October 2021
- journal article
- research article
- Published by Springer Nature in GeroScience
- Vol. 43 (6) , 2785-2793
Abstract
Immunosenescence, vascular aging, and brain aging, all characterized by elevated levels of inflammatory markers, are thought to share a common pathogenetic pathway: inflamm-aging. Retrospective cross-sectional analysis was conducted using data from the Mugello study (Tuscany, Italy), a representative Italian cohort of free-living nonagenarians. to assess the association between specific peripheral inflammation markers derived from white blood cell counts, and the diagnosis of dementia. All the variables of interest were reported for 411 subjects (110 males and 301 females) out of 475 enrolled in the study. Anamnestic dementia diagnosis was obtained from clinical certificate and confirmed by a General Practitioner, whereas leukocyte ratios were directly calculated from white blood cell counts. Body mass index and comorbidities were considered potential confounders. Diagnosis of any type dementia was certified in 73 cases (17.8%). Subjects affected by dementia were older, more frequently reported a previous stroke, had lower body mass index, and lower Mini-Mental-State-Examination score. Moreover, they had a higher lymphocyte count and lymphocyte-to-monocyte ratio compared to the non-demented nonagenarians. We found that higher levels of lymphocyte counts are cross-sectionally associated with a clinical diagnosis of dementia. Furthermore, lymphocyte-to-monocyte ratio is directly associated with any type of dementia, independently of age, sex, lymphocyte count, and comorbidities. Lymphocyte-to-monocyte ratio may be considered a marker of immunological changes in the brain of dementia patients; moreover, it is low-cost, and easily available, thus enabling comparisons among different studies and populations, although the timeline and the extent of lymphocyte-to-monocyte ratio role in dementia development must be further investigated.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 38 references indexed in Scilit:
- Sex differences in immune responsesNature Reviews Immunology, 2016
- How neuroinflammation contributes to neurodegenerationScience, 2016
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular CarcinomaClinical Cancer Research, 2014
- The Mugello Study, a survey of nonagenarians living in Tuscany: Design, methods and participants' general characteristicsEuropean Journal of Internal Medicine, 2013
- Immune System, Cell Senescence, Aging and Longevity - Inflamm-Aging Reappraised2013
- Lymphocyte to monocyte ratio as a screening tool for influenzaPLoS Currents, 2010
- The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancerSurgery, 2008
- Subsystems Contributing to the Decline in Ability to Walk: Bridging the Gap Between Epidemiology and Geriatric Practice in the InCHIANTI StudyJournal of the American Geriatrics Society, 2000
- The Relationships Between Age, Sex, and the Incidence of Dementia and Alzheimer DiseaseArchives of General Psychiatry, 1998
- Use of the neutrophil:lymphocyte ratio in the diagnosis of appendicitis.1995